AALRX
Price
$28.74
Change
-$0.04 (-0.14%)
Updated
Sep 8 closing price
Net Assets
3.41B
VIVIX
Price
$71.06
Change
-$0.13 (-0.18%)
Updated
Sep 8 closing price
Net Assets
202.84B
Interact to see
Advertisement

AALRX vs VIVIX

Header iconAALRX vs VIVIX Comparison
Open Charts AALRX vs VIVIXBanner chart's image
American Beacon Large Cap Value R6
Price$28.74
Change-$0.04 (-0.14%)
VolumeN/A
Net Assets3.41B
Vanguard Value Index I
Price$71.06
Change-$0.13 (-0.18%)
VolumeN/A
Net Assets202.84B
AALRX vs VIVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
AALRX vs. VIVIX commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AALRX is a StrongBuy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 203B vs. AALRX (3.41B). VIVIX pays higher dividends than AALRX: VIVIX (2.11) vs AALRX (1.61). AALRX was incepted earlier than VIVIX: AALRX (9 years) vs VIVIX (27 years). AALRX (0.62) is less costly to investors than VIVIX (0.04). AALRX is a more actively managed with annual turnover of: 26.00 vs. VIVIX (9.00). AALRX has a lower initial minimum investment than VIVIX: AALRX (0) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 7.74 vs. AALRX (0.31). VIVIX return over 5 years is better than : 70.16 vs. AALRX (29.26).
AALRXVIVIXAALRX / VIVIX
Total Expense Ratio0.620.041,550%
Annual Report Gross Expense Ratio0.620.041,550%
Fund Existence9 years27 years-
Gain YTD9.3887.866119%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets3.41B203B2%
Annual Yield % from dividends1.612.1176%
Returns for 1 year0.317.744%
Returns for 3 years18.9036.6152%
Returns for 5 years29.2670.1642%
Returns for 10 yearsN/A131.61-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LYFCX12.990.21
+1.64%
AlphaCentric Life Sciences & Hlthcare C
JEMWX37.580.41
+1.10%
JPMorgan Emerging Markets Equity R6
CLARX8.190.06
+0.74%
NYLI CBRE Real Estate Class A
IMIDX23.310.16
+0.69%
Congress Mid Cap Growth Institutional
MXYKX5.32-0.14
-2.56%
Empower T. Rowe Price Mid Cp Gr Instl